Filed: 8/14/2026ACC: 0001420506-26-001803
📋 What this filing means
OPALEYE MANAGEMENT INC. filed this quarterly 13F‑HR report disclosing 58 equity positions with a total reported market value of $1.10B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
58
Positions
$1.10B
Total AUM (reported)
65.60M
Total Shares
Allocation by class
COM$775.29M70.2%
COM NEW$287.45M26.0%
SHS NEW$37.63M3.4%
COM SHS$1.75M0.2%
ORD SHS$1.31M0.1%
SHS$749.0K0.1%
Portfolio Concentration
Top 3$400.60M36.3%
4–10$314.47M28.5%
11–25$262.05M23.7%
Rest$127.05M11.5%
Top 3 weight
36.3%
Top 10 weight
64.8%
Voting Authority Distribution
Total shares with voting rights: 65.60M
Sole
Full voting authority
65.60M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole58
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings58
Rows:
LIQUIDIA CORPORATION
SOLEShares2.45M
TypeSH
Market value$195.14M
17.67%
Sole
2.45M
Shared
0.00
None
0.00
ETON PHARMACEUTICALS INC
SOLEShares2.86M
TypeSH
Market value$103.53M
9.38%
Sole
2.86M
Shared
0.00
None
0.00
HARROW INC
SOLEShares2.40M
TypeSH
Market value$101.93M
9.23%
Sole
2.40M
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares855K
TypeSH
Market value$62.53M
5.66%
Sole
855K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares1.44M
TypeSH
Market value$52.99M
4.80%
Sole
1.44M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares390K
TypeSH
Market value$51.76M
4.69%
Sole
390K
Shared
0.00
None
0.00
MEIRAGTX HLDGS PLC
SOLEShares3.55M
TypeSH
Market value$47.96M
4.34%
Sole
3.55M
Shared
0.00
None
0.00
SOL-GEL TECHNOLOGIES LTD
SOLEShares500K
TypeSH
Market value$37.07M
3.36%
Sole
500K
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares6.30M
TypeSH
Market value$32.76M
2.97%
Sole
6.30M
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares535K
TypeSH
Market value$29.39M
2.66%
Sole
535K
Shared
0.00
None
0.00
IMMIX BIOPHARMA INC
SOLEShares2.35M
TypeSH
Market value$24.18M
2.19%
Sole
2.35M
Shared
0.00
None
0.00
CRESCENT BIOPHARMA INC.
SOLEShares1.32M
TypeSH
Market value$23.75M
2.15%
Sole
1.32M
Shared
0.00
None
0.00
STOKE THERAPEUTICS INC
SOLEShares700K
TypeSH
Market value$22.90M
2.07%
Sole
700K
Shared
0.00
None
0.00
ALPHA COGNITION INC
SOLEShares2.90M
TypeSH
Market value$20.91M
1.89%
Sole
2.90M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares500K
TypeSH
Market value$20.32M
1.84%
Sole
500K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares100K
TypeSH
Market value$18.73M
1.70%
Sole
100K
Shared
0.00
None
0.00
MONTE ROSA THERAPEUTICS INC
SOLEShares745K
TypeSH
Market value$18.03M
1.63%
Sole
745K
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares550K
TypeSH
Market value$15.48M
1.40%
Sole
550K
Shared
0.00
None
0.00
CODEXIS INC
SOLEShares6.79M
TypeSH
Market value$15.33M
1.39%
Sole
6.79M
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares1.38M
TypeSH
Market value$15.33M
1.39%
Sole
1.38M
Shared
0.00
None
0.00
XOMA ROYALTY CORPORATION
SOLEShares338.37K
TypeSH
Market value$14.38M
1.30%
Sole
338.37K
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
SOLEShares260K
TypeSH
Market value$14.35M
1.30%
Sole
260K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares122.50K
TypeSH
Market value$13.60M
1.23%
Sole
122.50K
Shared
0.00
None
0.00
EDITAS MEDICINE INC
SOLEShares3.86M
TypeSH
Market value$12.51M
1.13%
Sole
3.86M
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares100K
TypeSH
Market value$12.26M
1.11%
Sole
100K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
LIQUIDIA CORPORATIONSOLE | COM NEW | 2.45M | SH | $195.14M 17.67% | 2.45M | 0.00 | 0.00 |
ETON PHARMACEUTICALS INCSOLE | COM | 2.86M | SH | $103.53M 9.38% | 2.86M | 0.00 | 0.00 |
HARROW INCSOLE | COM | 2.40M | SH | $101.93M 9.23% | 2.40M | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 855K | SH | $62.53M 5.66% | 855K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 1.44M | SH | $52.99M 4.80% | 1.44M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 390K | SH | $51.76M 4.69% | 390K | 0.00 | 0.00 |
MEIRAGTX HLDGS PLCSOLE | COM | 3.55M | SH | $47.96M 4.34% | 3.55M | 0.00 | 0.00 |
SOL-GEL TECHNOLOGIES LTDSOLE | SHS NEW | 500K | SH | $37.07M 3.36% | 500K | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 6.30M | SH | $32.76M 2.97% | 6.30M | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 535K | SH | $29.39M 2.66% | 535K | 0.00 | 0.00 |
IMMIX BIOPHARMA INCSOLE | COM | 2.35M | SH | $24.18M 2.19% | 2.35M | 0.00 | 0.00 |
CRESCENT BIOPHARMA INC.SOLE | COM | 1.32M | SH | $23.75M 2.15% | 1.32M | 0.00 | 0.00 |
STOKE THERAPEUTICS INCSOLE | COM | 700K | SH | $22.90M 2.07% | 700K | 0.00 | 0.00 |
ALPHA COGNITION INCSOLE | COM NEW | 2.90M | SH | $20.91M 1.89% | 2.90M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 500K | SH | $20.32M 1.84% | 500K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 100K | SH | $18.73M 1.70% | 100K | 0.00 | 0.00 |
MONTE ROSA THERAPEUTICS INCSOLE | COM | 745K | SH | $18.03M 1.63% | 745K | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 550K | SH | $15.48M 1.40% | 550K | 0.00 | 0.00 |
CODEXIS INCSOLE | COM | 6.79M | SH | $15.33M 1.39% | 6.79M | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 1.38M | SH | $15.33M 1.39% | 1.38M | 0.00 | 0.00 |
XOMA ROYALTY CORPORATIONSOLE | COM NEW | 338.37K | SH | $14.38M 1.30% | 338.37K | 0.00 | 0.00 |
MBX BIOSCIENCES INCSOLE | COM | 260K | SH | $14.35M 1.30% | 260K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 122.50K | SH | $13.60M 1.23% | 122.50K | 0.00 | 0.00 |
EDITAS MEDICINE INCSOLE | COM | 3.86M | SH | $12.51M 1.13% | 3.86M | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 100K | SH | $12.26M 1.11% | 100K | 0.00 | 0.00 |
Page 1 of 3